advertisement
Abstract #18364 Published in IGR 3-3
Bimatoprost: a member of a new class of agents, the prostamides for glaucoma management
Hommer A; Kaminski ST; Huber-Spitzy VSpektrum der Augenheilkunde 2001; 15: 146-149
Bimatoprost belongs to a newly discovered class of compounds, named prostamides, which have been shown to have potent ocular hypotensive activity in animals. Bimatoprost mimics the endogenous prostamides by lowering intraocular pressure (IOP). Bimatoprost provides outstanding control of IOP throughout the day, and furthermore, a high percentage of patients receiving bimatoprost achieve the low target pressures ('target IOP'), which is very important to clinical success. In controlled clinical trials, Bimatoprost given once daily displayed efficacy superior to timolol given twice daily. LA: German
Dr. A. Hommer, Augenabteilung, Krankenanstalt Sanatorium Hera, Loeblichgasse 14, 1090 Vienna, Austria
Classification:
11.4 Prostaglandins (Part of: 11 Medical treatment)
